AMIDEBIO, LLC

Home | Amidebio | Novel Peptides Targeting Metabolic Disease

Boulder, United States · Founded 2017 · $6.8M raised

Headquarters
Boulder, Colorado
Employees
1–10
Founded
2017
Business Model
B2B
Total Funding
$6.8M
Last Round
$1.9M GrantSep 2024
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

AmideBio discovers peptide therapeutics for metabolic disease, using advanced in-silico techniques to intelligently design novel peptides and its proprietary BioPure process to efficiently manufacture them, alongside testing schemes to quickly assess their biological activity. The company's goal is to license these drug candidates to the biopharmaceutical industry and research community at or before the Investigational New Drug (IND) stage.

Summary

AMIDEBIO, LLC is a Biotech company based in Boulder, United States, founded in 2017. It has raised $6.8M in total across 5 rounds, most recently a $1.9M Grant round in Sep 2024.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantSBIR Phase II (NIH)Sep 2024
$1.9M

Sign up to see all 5 events

Funding: Grant. Amounts, valuations, and investors where available.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

AMIDEBIO, LLC on Indexed.vc
<a href="https://indexed.vc/companies/amidebio-llc"><img src="https://indexed.vc/api/badge/company/amidebio-llc" alt="AMIDEBIO, LLC on Indexed.vc" width="260" height="76" /></a>